Hikma Is Halted By US Everolimus Method-Of-Use Patent

 
• By Aidan Fry
  
Barrier
An adverse US appeals ruling could prevent Hikma from offering a generic of Afinitor until 2026 • Source: Shutterstock

More from Legal & IP

More from Generics Bulletin